Omar Y. Mian

2.1k total citations
85 papers, 907 citations indexed

About

Omar Y. Mian is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Omar Y. Mian has authored 85 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 27 papers in Oncology. Recurrent topics in Omar Y. Mian's work include Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Prostate Cancer Treatment and Research (17 papers). Omar Y. Mian is often cited by papers focused on Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Prostate Cancer Treatment and Research (17 papers). Omar Y. Mian collaborates with scholars based in United States, Canada and Finland. Omar Y. Mian's co-authors include Paul M. Hwang, Satoaki Matoba, Willmar D. Patino, Tammy Nguyen, Yukitaka Shizukuda, Ju‐Gyeong Kang, Merlin Nithya Gnanapragasam, Gordon D. Ginder, Rahul D. Tendulkar and Kevin L. Stephans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Omar Y. Mian

70 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Y. Mian United States 19 385 269 200 172 108 85 907
Cheng‐Bo Han China 17 270 0.7× 471 1.8× 381 1.9× 190 1.1× 59 0.5× 76 864
Liyi Xie China 16 345 0.9× 222 0.8× 239 1.2× 276 1.6× 232 2.1× 54 1.1k
Andrew Gaya United Kingdom 17 243 0.6× 285 1.1× 410 2.0× 150 0.9× 204 1.9× 38 1.2k
Aradhana Kaushal United States 20 341 0.9× 577 2.1× 203 1.0× 176 1.0× 213 2.0× 38 1.3k
Paul N. Staats United States 20 183 0.5× 231 0.9× 199 1.0× 126 0.7× 194 1.8× 61 1.0k
Shisuo Du China 18 412 1.1× 241 0.9× 471 2.4× 212 1.2× 127 1.2× 77 1.2k
Tatsuhiko Kakisaka Japan 15 326 0.8× 187 0.7× 259 1.3× 156 0.9× 229 2.1× 65 886
Weijian Guo China 15 304 0.8× 572 2.1× 589 2.9× 170 1.0× 262 2.4× 72 1.4k
Sukhmani K. Padda United States 21 368 1.0× 640 2.4× 724 3.6× 181 1.1× 118 1.1× 94 1.5k
S. Gerum Germany 14 160 0.4× 293 1.1× 342 1.7× 126 0.7× 424 3.9× 32 1.1k

Countries citing papers authored by Omar Y. Mian

Since Specialization
Citations

This map shows the geographic impact of Omar Y. Mian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Y. Mian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Y. Mian more than expected).

Fields of papers citing papers by Omar Y. Mian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Y. Mian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Y. Mian. The network helps show where Omar Y. Mian may publish in the future.

Co-authorship network of co-authors of Omar Y. Mian

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Y. Mian. A scholar is included among the top collaborators of Omar Y. Mian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Y. Mian. Omar Y. Mian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corredor, Germán, Elizabeth M. Genega, Omar Y. Mian, et al.. (2025). AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma. Cancer Letters. 634. 218059–218059.
2.
Reddy, C.A., Muhammad Hassan, Parag Jain, et al.. (2025). Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy. JCO Clinical Cancer Informatics. 9(9). e2400292–e2400292. 1 indexed citations
3.
Ornstein, Moshe Chaim, Shilpa Gupta, Jesse K. McKenney, et al.. (2024). A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC). Urologic Oncology Seminars and Original Investigations. 42. S31–S31.
4.
Jong, Joep J. de, Tarek A. Bismar, Stephen A. Boorjian, et al.. (2024). Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers. Urologic Oncology Seminars and Original Investigations. 42(6). 177.e5–177.e14. 1 indexed citations
5.
Mian, Omar Y., et al.. (2024). Patient‐specific adaptive planning margin for whole bladder radiation therapy. Journal of Applied Clinical Medical Physics. 26(4). e14617–e14617.
6.
Makarov, Vladimir, Scott J. Dawsey, Paul G. Pavicic, et al.. (2024). Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.. Journal of Clinical Oncology. 42(4_suppl). 670–670. 1 indexed citations
7.
Stephans, Kevin L., Andrew Godley, A. Magnelli, et al.. (2023). Transperineal ultrasound is a good alternative for intra‐fraction motion monitoring for prostate stereotactic body radiotherapy. Journal of Applied Clinical Medical Physics. 24(10). e14021–e14021. 3 indexed citations
8.
Gupta, Shilpa, Christopher Weight, Nima Almassi, et al.. (2023). Trial in Progress: Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients with MIBC (RAD-SG). International Journal of Radiation Oncology*Biology*Physics. 117(2). e447–e448. 1 indexed citations
9.
Hardaway, Aimalie, Timothy D. Smile, Elai Davicioni, et al.. (2023). Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer. Journal of Clinical Investigation. 133(22). 5 indexed citations
10.
Nguyen, Jane, et al.. (2023). Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. Frontiers in Endocrinology. 14. 21 indexed citations
11.
Broughman, James R., et al.. (2020). Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer. Current Treatment Options in Oncology. 22(1). 3–3. 6 indexed citations
12.
Fallah, Jaleh, C. Marcela Díaz‐Montero, Patricia Rayman, et al.. (2020). Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival. Clinical Genitourinary Cancer. 18(6). 500–508. 8 indexed citations
13.
Tendulkar, Rahul D., et al.. (2019). Monitoring Intra-Fraction Prostate Motion Using Kv Triggered Imaging during SBRT. International Journal of Radiation Oncology*Biology*Physics. 105(1). E749–E749.
14.
Reddy, C.A., Rupesh Kotecha, Chirag Shah, et al.. (2019). Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 104(2). 325–333. 22 indexed citations
15.
Bae, Hee‐Joon, Gayane Yenokyan, Yi Le, et al.. (2017). Reductions in prostatic doses are associated with less acute morbidity in patients undergoing Pd-103 brachytherapy: Substantiation of the rationale for focal therapy. Brachytherapy. 17(2). 313–318. 6 indexed citations
16.
Haffner, Michael C., Jonathan B. Coulter, Raju R. Raval, et al.. (2016). Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation. Clinical Cancer Research. 22(13). 3310–3319. 33 indexed citations
17.
Mian, Omar Y., Shou Zhen Wang, Sheng Zu Zhu, et al.. (2011). Methyl-Binding Domain Protein 2–Dependent Proliferation and Survival of Breast Cancer Cells. Molecular Cancer Research. 9(8). 1152–1162. 40 indexed citations
18.
Ginder, Gordon D., Merlin Nithya Gnanapragasam, & Omar Y. Mian. (2008). Chapter 4 The Role of the Epigenetic Signal, DNA Methylation, in Gene Regulation During Erythroid Development. Current topics in developmental biology. 82. 85–116. 23 indexed citations
19.
Patino, Willmar D., Ju‐Gyeong Kang, Satoaki Matoba, et al.. (2006). Atherosclerotic Plaque Macrophage Transcriptional Regulators Are Expressed in Blood and Modulated by Tristetraprolin. Circulation Research. 98(10). 1282–1289. 40 indexed citations
20.
Shizukuda, Yukitaka, Satoaki Matoba, Omar Y. Mian, Tammy Nguyen, & Paul M. Hwang. (2005). Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Molecular and Cellular Biochemistry. 273(1-2). 25–32. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026